शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
SANOFINSESANOFI INDIA LIMITED· Pharmaceuticals & BiotechnologyHighNegative
Announced Fri, 25 Sept, 2026 · 22:38 IST

GST Show Cause Notice to Sanofi India over Rs 23.74 crore tax demand

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.9%Reaction day
₹3143.40
prior close
₹3143.40
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.6%-0.3% vs market
Pharmaceuticals peers, median of 172sector-1.5%-0.5% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.6
10m
-0.4
15m
-0.7
30m
-1.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.9-1.6-0.3-1.5-0.5
Next day
-2.3-0.6-1.7-1.0-1.3
2d
-2.9-0.8-2.1-1.9-1.1
3d
-3.3-2.1-1.2-2.4-0.9
4d
-3.9-2.1-1.8-3.2-0.7
5d
-3.1-0.8-2.3-2.4-0.7
1w
-5.6-3.8-1.8-4.2-1.4
15d
-10.0-6.9-3.1-7.8-2.1
1m
-4.6-8.0+3.4-6.6+2.0
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sanofi India received a Show Cause Notice from Karnataka GST authorities dated 25 September 2026 alleging excess claim of Input Tax Credit for FY 2022-23. Proposed tax demand is Rs 14.43 crore plus interest of Rs 9.31 crore, totaling about Rs 23.74 crore. The company is examining the notice and plans to file a reply. It says it does not expect any adverse impact on its financials, operations or activities from this notice.

Likely market impact

Tax dispute at notice stage; company expects no material financial impact. Demand of about Rs 23.74 crore is modest for Sanofi India.